Xenon Pharmaceuticals Inc. (XENE)
NASDAQ: XENE · Real-Time Price · USD
59.74
+2.96 (5.21%)
At close: Jun 26, 2026, 4:00 PM EDT
60.10
+0.36 (0.60%)
After-hours: Jun 26, 2026, 4:54 PM EDT
Xenon Pharmaceuticals Employees
As of December 31, 2025, Xenon Pharmaceuticals had 370 total employees, including 358 full-time and 12 part-time employees. The number of employees increased by 43 or 13.15% compared to the previous year.
Employees
370
Change (1Y)
43
Growth (1Y)
13.15%
Revenue / Employee
n/a
Profits / Employee
-$1,035,581
Market Cap
5.77B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Legend Biotech | 2,965 |
| Caris Life Sciences | 1,846 |
| Travere Therapeutics | 497 |
| CRISPR Therapeutics AG | 393 |
| CG Oncology | 142 |
| Definium Therapeutics | 106 |
| Dianthus Therapeutics | 92 |
| Oruka Therapeutics | 68 |
XENE News
- 23 days ago - Xenon Pharmaceuticals Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 4 weeks ago - Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 weeks ago - Xenon Pharmaceuticals price target raised to $82 from $80 at JPMorgan - TheFly
- 5 weeks ago - Xenon Pharmaceuticals Transcript: RBC Capital Markets Global Healthcare Conference 2026 - Transcripts
- 6 weeks ago - Xenon Pharmaceuticals Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts
- 6 weeks ago - Xenon Pharmaceuticals price target raised to $80 from $77 at JPMorgan - TheFly
- 6 weeks ago - Xenon Pharmaceuticals price target raised to $69 from $68 at Wells Fargo - TheFly
- 7 weeks ago - Xenon Pharmaceuticals price target lowered to $78 from $80 at Needham - TheFly